| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.61B | -6.2% |
| R&D Expense | $13.4M | -22.1% |
| SG&A Expense | $76.0M | -14.1% |
| Operating Income | $81.1M | -13.8% |
| Pre-tax Income | $86.3M | -11.9% |
| Income Tax | $34.7M | -24.7% |
| Net Income | $51.7M | -0.4% |
| EPS (Basic) | $0.45 | +0.0% |
| EPS (Diluted) | $0.45 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $196.1M | +7.1% |
| Accounts Receivable | $477.0M | -7.8% |
| Inventory | $167.9M | +5.6% |
| Current Assets | $960.3M | -0.4% |
| Total Assets | $2.26B | -3.2% |
| Current Liabilities | $443.7M | -8.4% |
| Long-term Debt | $79.1M | -34.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $210.2M | +24.0% |
| Capital Expenditures | $112.4M | -21.7% |
| Investing Cash Flow | -$107.4M | +35.0% |
| Financing Cash Flow | -$96.7M | -427.1% |
| Free Cash Flow | $97.8M | +277.5% |
| Total Liabilities |
| $725.3M |
| -13.9% |
| Stockholders' Equity | $1.53B | +2.9% |